STOCK TITAN

Centessa Pharmaceuticals plc American (CNTA) Free Cash Flow by Year

CNTA NASDAQ

Centessa Pharmaceuticals plc American recorded an outflow of $194.2M in free cash flow in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Centessa Pharmaceuticals plc American has filed alongside them.

FY2025 annual
Free Cash Flow -$194.2M
YoY n/m
5Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CNTA Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Free Cash Flow-$194.2Mn/m-$142.1Mn/m-$160.5Mn/m-$201.7Mn/m-$135.3Mn/m-$10.6Mn/m-$5.8M

CNTA Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Free Cash FlowN/A-$55.8Mn/m-$58.5Mn/mN/AN/A-$42.8Mn/m-$21.4Mn/m-$40.6Mn/m-$37.3Mn/m-$31.1Mn/m-$37.4Mn/m-$44.1Mn/m

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Centessa Pharmaceuticals plc American financials

Frequently Asked Questions

What was Centessa Pharmaceuticals plc American's free cash flow in fiscal year 2025?

Centessa Pharmaceuticals plc American recorded an outflow of $194.2M in free cash flow in fiscal year 2025.

How fast is Centessa Pharmaceuticals plc American's free cash flow growing?

Centessa Pharmaceuticals plc American (CNTA) reported an outflow of $142.1M in free cash flow in fiscal year 2024 and an outflow of $194.2M in free cash flow in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

How has Centessa Pharmaceuticals plc American's free cash flow changed over the years?

Across the 7 fiscal years this page covers, Centessa Pharmaceuticals plc American (CNTA) free cash flow went from -$5.8M in fiscal year 2019 to -$194.2M in fiscal year 2025.

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Centessa Pharmaceuticals plc American (CNTA) reported on that line in every period on record.